Koji Yamanaka

23PUBLICATIONS
33CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Psychosocial aspects of childbirth and perinatal mental healthOptometryAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 05, 2026
TBK1 eliminates aggregation-prone monomeric TDP-43 through an IFNβ-immunoproteasome pathway in ALS models.

|May 05, 2025
Mitochondria and Endoplasmic Reticulum Contact Site as a Regulator of Proteostatic Stress Responses in Neurodegenerative Diseases.

Seiji Watanabe, Koji Yamanaka

|Jan 17, 2025
Prenatal inflammation impairs early CD11c-positive microglia induction and delays myelination in neurodevelopmental disorders.

Kazuya Fuma, Yukako Iitani, Kenji Imai

|Nov 28, 2024
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice.

Mai Horiuchi, Seiji Watanabe, Okiru Komine

|Nov 25, 2024
Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer's disease mice by controlling astrocyte activation.

Akira Sobue, Okiru Komine, Fumito Endo

|Jan 12, 2024
An open chat with… Koji Yamanaka.

Ioannis Tsagakis, Koji Yamanaka

Pageof 4

Frequent Collaborators

6 joint publications

Okiru Komine

6 joint publications

Seiji Watanabe

2 joint publications

Masato Koike

2 joint publications

Toshihide Yamashita